Biocardia
Price & Volume
Stats
See more52W Range | $0.84-$2.45 |
Market Cap | $10.4M |
Shares Short | 245,775 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$4.6M |
Diluted EPS | -$0.85 |
News
See moreYahoo Finance • 22 days ago
BioCardia Aligns With FDA On Helix Transendocardial Delivery Catheter Marketing Pathways
Yahoo Finance • 2 months ago
BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026
Yahoo Finance • 2 months ago
BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA
Yahoo Finance • 6 months ago
BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress
About
CEO | Dr. Peter A. Altman Ph.D. |
Address | 320 Soquel Way, Sunnyvale, CA, United States, 94085 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |